ArticleKidney cancer (Clifton, Va.)2024

Effectiveness of Second-Line Cabozantinib in Metastatic Clear Cell Renal Cell Carcinoma Patients After First-Line Treatment with Immune Checkpoint Inhibitor-based Combinations.

Arshit Narang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.